Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2

Journal of Inflammation

Volumn 2, Issue , 2005, Pages

  Scherübl, Christoph ^a   Schneider Brachert, Wulf ^b   Schütze, Stephan ^c   Hehlgans, Thomas ^a   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Institute of Medical Microbiology and Hygiene   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL ISOLATION; CELL SURFACE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; EMBRYO; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RECEPTOR BINDING; TRANS GOLGI NETWORK; WESTERN BLOTTING;

EID: 23944450413     PISSN: 14769255     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-9255-2-7     Document Type: Article

References (53)

1. Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65.
2. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV: Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci U S A 1991, 88:2830-2834.
3. Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W: Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990, 61:351-359.
4. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H, .: Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990, 61:361-370.
5. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990, 248:1019-1023.
6. Smith CA, Farrah T, Goodwin RG: The TNF receptor super-family of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 76:959-962.
7. Vercammen D, Vandenabeele P, Declercq W, Van de CM, Grooten J, Fiers W: Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Cytokine 1995, 7:463-470.
8. Mason AT, McVicar DW, Smith CA, Young HA, Ware CF, Ortaldo JR: Regulation of NK cells through the 80-kDa TNFR (CD120b). J Leukoc Biol 1995, 58:249-255.
9. Erikstein BK, Smeland EB, Blomhoff HK, Funderud S, Prydz K, Lesslauer W, Espevik T: Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol 1991, 21:1033-1037.
10. Grell M, Becke FM, Wajant H, Mannel DN, Scheurich P: TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur J Immunol 1998, 28:257-263.
11. Tartaglia LA, Goeddel DV, Reynolds C, Figari IS, Weber RF, Fendly BM, Palladino MAJ: Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 1993, 151:4637-4641.
12. Vandenabeele P, Declercq W, Vercammen D, Van de CM, Grooten J, Loetscher H, Brockhaus M, Lesslauer W, Fiers W: Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J Exp Med 1992, 176:1015-1024.
13. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, .: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995, 83:793-802.
14. Haridas V, Darnay BG, Natarajan K, Heller R, Aggarwal BB: Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J Immunol 1998, 160:3152-3162.
15. Heller RA, Song K, Fan N, Chang DJ: The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992, 70:47-56.
16. Porteu F, Nathan C: Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990, 172:599-607.
17. Lantz M, Bjornberg F, Olsson I, Richter J: Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J Immunol 1994, 152:1362-1369.
18. Crowe PD, VanArsdale TL, Goodwin RG, Ware CF: Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J Immunol 1993, 151:6882-6890.
19. Aderka D, Sorkine P, Abu-Abid S, Lev D, Setton A, Cope AP, Wallach D, Klausner J: Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J Clin Invest 1998, 101:650-659.
20. Aderka D, Englemann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G: Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991, 51:5602-5607.
21. Hober D, Benyoucef S, Delannoy AS, De Groote D, Ajana F, Mouton Y, Wattre P: High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients. Infection 1996, 24:213-217.
22. Schroder J, Stuber F, Gallati H, Schade FU, Kremer B: Pattern of soluble TNF receptors I and II in sepsis. Infection 1995, 23:143-148.
23. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M: Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992, 35:1160-1169.
24. Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M, .: Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993, 36:1111-1120.
25. Lainez B, Fernandez-Real JM, Romero X, Esplugues E, Canete JD, Ricart W, Engel P: Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. Int Immunol 2004, 16:169-177.
26. Seitz C, Muller P, Krieg RC, Mannel DN, Hehlgans T: A Novel p75TNF Receptor Isoform Mediating NFk B Activation. J Biol Chem 2001, 276:19390-19395.
27. Singer SS, Mannel DN, Hehlgans T, Brosius J, Schmitz J: From "Junk" to Gene: Curriculum vitae of a Primate Receptor Isoform Gene. Journal of Molecular Biology 2004, 342:883-886.
28. Krippner-Heidenreich A, Tubing F, Bryde S, Willi S, Zimmermann G, Scheurich P: Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction. J Biol Chem 2002, 277:44155-44163.
29. Grell M, Scheurich P, Meager A, Pfizenmaier K: TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 1993, 12:143-148.
30. Naviaux RK, Costanzi E, Haas M, Verma IM: The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996, 70:5701-5705.
31. Sambrook J, Russel DW: Molecular cloning: A laboratory manual. Molecular cloning: A laboratory manual 2001, 3nd Ed.:Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, Mentlein R, Kabelitz D, Schutze S: Compartmentalization of TNF Receptor 1 Signaling; Internalized TNF Receptosomes as Death Signaling Vesicles. Immunity 2004, 21:415-428.
33. Pedron T, Girard R, Chaby R: TLR4-dependent lipopolysaccharide-induced shedding of tumor necrosis factor receptors in mouse bone marrow granulocytes. J Biol Chem 2003, 278:20555-20564.
34. Pimentel-Muinos FX, Seed B: Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 1999, 11:783-793.
35. Corti A, D'Ambrosio F, Marino M, Merli S, Cassani G: Identification of differentially glycosylated forms of the soluble p75 tumor necrosis factor (TNF) receptor in human urine. Eur Cytokine Netw 1995, 6:29-35.
36. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL: A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci U S A 1990, 87:8331-8335.
37. Pennica D, Lam VT, Mize NK, Weber RF, Lewis M, Fendly BM, Lipari MT, Goeddel DV: Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation. J Biol Chem 1992, 267:21172-21178.
38. Schutze S, Machleidt T, Adam D, Schwandner R, Wiegmann K, Kruse ML, Heinrich M, Wickel M, Kronke M: Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J Biol Chem 1999, 274:10203-10212.
39. Bradley JR, Thiru S, Pober JS: Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995, 146:27-32.
40. Ledgerwood EC, Prins JB, Bright NA, Johnson DR, Wolfreys K, Pober JS, O'Rahilly S, Bradley JR: Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized. Lab Invest 1998, 78:1583-1589.
41. Mosselmans R, Hepburn A, Dumont JE, Fiers W, Galand P: Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J Immunol 1988, 141:3096-3100.
42. Jones SJ, Ledgerwood EC, Prins JB, Galbraith J, Johnson DR, Pober JS, Bradley JR: TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 1999, 162:1042-1048.
43. Prinz B, Stahl U, Lang C: Intracellular transport of a heterologous membrane protein, the human transferrin receptor, in Saccharomyces cerevisiae. Int Microbiol 2003, 6:49-55.
44. Zerial M, Melancon P, Schneider C, Garoff H: The transmembrane segment of the human transferrin receptor functions as a signal peptide. EMBO J 1986, 5:1543-1550.
45. Wang J, Al Lamki RS, Zhang H, Kirkiles-Smith N, Gaeta ML, Thiru S, Pober JS, Bradley JR: Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool. J Biol Chem 2003, 278:21751-21760.
46. Hawari FI, Rouhani FN, Cui X, Yu ZX, Buckley C, Kaler M, Levine SJ: Release of full-length 55-kDa TNF receptor 1 in exosomelike vesicles: a mechanism for generation of soluble cytokine receptors. Proc Natl Acad Sci U S A 2004, 101:1297-1302.
47. Grell M, Wajant H, Zimmermann G, Scheurich P: The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci U S A 1998, 95:570-575.
48. Shurety W, Merino-Trigo A, Brown D, Hume DA, Stow JL: Localization and post-Golgi trafficking of tumor necrosis factor-alpha in macrophages. J Interferon Cytokine Res 2000, 20:427-438.
49. Decoster E, Vanhaesebroeck B, Boone E, Plaisance S, De Vos K, Haegeman G, Grooten J, Fiers W: Induction of unresponsiveness to tumor necrosis factor (TNF) after autocrine TNF expression requires TNF membrane retention. J Biol Chem 1998, 273:3271-3277.
50. Beg AA, Baldwin ASJ: Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor. Oncogene 1994, 9:1487-1492.
51. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 1995, 267:1485-1488.
52. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789.
53. Kim EY, Teh HS: Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28. J Immunol 2004, 173:4500-4509.